Scientific Programme Introduction

21st Meeting of the European Venous Forum

Budapest Congress Centre, Budapest, Hungary

24-26 June 2021


Click here to view the online Programme

Click here to download the Programme




Abstract Session 1: (10 minute presentation, 10 minute discussion)

Venous Thromboembolism, Anticoagulation, Iliac Stenting, Villalta Scale  |  Chair: I Bihari (Hungary), A Nicolaides (Cyprus)

08.30             1.1

Comparison of thrombus regression between direct oral anticoagulants and warfarin in patients with deep vein thrombosis.

Hosoi Yutaka; Nunokawa Masao; Mochizuki Yasuaki; Ichikawa Yohei; Sasajima Hiroshi; Fujimaki Keisuke; Kubota, Hiroshi.

Cardiovascular Surgery, Kyorin University, Tokyo, Japan

08.50             1.2

Gender-related hemorrhagic events during rivaroxaban therapy.

Dzhenina Olga; Bogachev Vadim. 

First Phlebological Centre, Moscow, Russia

09.10            1.3

Comparative outcomes of venous thromboprophylaxis between low-molecular weight heparin (LMWH) and rivaroxaban in colorectal cancer surgery: A pilot randomized clinical trial.

Pornwaragorn Chaowanun; Bokerd Surakiat; Pootracool Piyanut; Tirapanich, Wiwat; Jirasiritham Sopon; Leelaudomlipi Surasak; Horsirimanont Suthas; Kittitirapong Nutsiri; Wilasrusmee Chumpon; Supsamutchai Chirat; Phuwapraisirisan Samart; Jirasiritham, Jakrapan. 

Department of Surgery, Faculty of Medicine Ramathibodi hospital, Bangkok, Thailand

Submitted for the EVF Prize

09.30              1.4

Risk factors and frequency of recurrent long-term venous thromboembolism after superficial vein thrombosis of the lower limbs.

Papageorgopoulou Chrysanthi P; Kakkos Stavros; Nikolakopoulos Konstantinos M; Ntouvas Ioannis; Papadoulas Spyros; Kouri Anastasia; Tsantrizos Polyzois.

Vascular Surgery, University Hospital of Patras, Patras, Greece

09.50             1.5

Quality of life outcomes after iliac vein stenting for chronic deep venous obstruction: a tertiary centre experience using the VEINES-QoL/SYM.

Morris Rachael; Pouncey Anna; Khan Taha; Gwozdz, Adam; Quintana, Belen; Saha Prakash; Black Stephen.

Academic Department of Vascular Surgery, School of Cardiovascular Medicine and Sciences, St Thomas’ Hospital, London, UK

Submitted for the EVF Prize

10.10             1.6

Assessment of the Villalta tool in a population with primary chronic venous disease.

Kemal Kemal; Onida Sarah; Davies Alun.

Imperial College London, London, UK

Submitted for the EVF Prize


Refreshments and visit to Exhibition  |  Visit Poster Presentations


Abstract Session 2: (10 minute presentation, 10 minute discussion)

Thermal ablation, Cyanoacrylate, Sclerotherapy, Hemodynamics  |  Chair: D Heim (Switzerland), A Szabo (Hungary)

11.00            2.1

Randomised clinical trial of mechanochemical ablation versus cyanoacrylate adhesive for the treatment of varicose veins (MOCCA).

Belramman Amjad1; Lane Tristan R A1; Bootun Roshan1; Tang Tjun Yip2; Davies Alun H1

1Imperial College London, London, London, UK; 2Singapore General Hospital and Sengkang General Hospital, Singapore., Singapore, Singapore

Submitted for the EVF Prize

11.20             2.2

Mid-term results of cyanoacrylate embolization for saphenous veins: efficacy, complications and their treatment.

Murzina Elena1; Lobastov Kirill2; Bargandzhiya Astanda2; Laberko Leonid2; Popov Ivan3

1Hospital «Neftyanik», Tyumen, Russia; 2Pirogov Russian National Research Medical University, Moscow, Russia; 3Tyumen State Medical University, Tyumen, Russia

11.40             2.3

Mechanisms of damage to the venous wall and dissolving venaseal glue in an animal experiment.

Markin SM.1; Mazayshvili KV.2; Agalarov RM.2; Gustelev YuA.2; Gitsuk YaV.1; Mordovin, A.I.1

1Federal State Budgetary Health Institution “St. Petersburg Clinical Hospital of the Russian Academy of Sciences, Saint-Petersburg, Russia; 2Department of Faculty Surgery, Surgical University, Surgut State University, Surgut, Russia

Submitted for the EVF Prize

12.00             2.4

Efficacy and safety of radiofrequency thermal ablation of great saphenous vein compared to saphenous-femoral junction ligature and stripping. A randomized exploratory study.

Reina-Gutierrez Lourdes1; Fernández-Solares Jose Ignacio1; Nowak-Tarnawska, Agnieszka1; Barrio-Rodriguez, Carlos1;Florez-Gonzalez, Aurora1;Laime-Alvarez, Ilsem1; Fernández-Pérez, Cristina2; Sanjuanbenito-Reina, Alfonso3.

1Vascular Department, Hospital Central de la Cruz Roja, Madrid, Spain; 2Epidemiology Unit, Hospital Clinico San Carlos, Madrid, Spain; 3Grade of Medicine, Autonoma University, Madrid, Spain

12.20             2.5

Ultrasound-guided foam sclerotherapy on larges great saphenous veins (over 8 mm diameter) with 1% vs 2% vs 3% polidocanol: A randomised trial.

Amorim Cláudia; Virgini-Magalhães Carlos Eduardo; Bandeira Julia.

Vascular and Endovascular Surgery, University Hospital Pedro Ernesto, Rio de Janeiro, Brazil

Submitted for the EVF Prize

12.40             2.6

The study of systemic hemodynamic disorders in patients with varicose veins and post-thrombotic syndrome.

Suchkov Igor; Kalinin Roman; Mzhavanadze Nina; Shanaev Ivan

Ryazan State Medical University, Ryazan, Russia

Submitted for the EVF Prize


Lunch and visit to Exhibition  |  ePoster Presentations


Industry Session 1


Didactic Session 1 (10 minute presentation, 5 minute discussion)

Messages from New Guidelines, Training of young phlebologists in Europe  |  Chair: TBA. F Zernovicky (Hungary)


Coronavirus and VTE.  TBA


Laser ablation, radiofrequency ablation, surgery and ultrasound guided foam sclerotherapy: what do the new guidelines say and how do we apply it in practice? A Giannoukas (Greece)


Compression: Messages from the International Guidelines. G Szolnoky (Hungary)


Laser crossectomy. I Bihari (Hungary)


Refreshments and visit to Exhibition  |  Visit e-Poster Presentations


Didactic Session 2 (10 minute presentation, 10 minute discussion)

Advanced CVD, MOCA, Cyanoacrylate, New devices  |  Chair: TBA, G Szolnoky (Hungary)


Endovenous procedures in patients with venous ulcers. G Menyhei (Hungary)


Cost-benefit of venous stenting. C Rognoni (Italy)


Venous insufficiency, barrier function of the microbiome and ulcer development. J Daróczy (Hungary)


MOCA: is it here to stay? A Szabó (Hungary)


Cyanoacrylate: Efficacy and Risks. T Proebstle (Germany)


Outlook into the future of VV therapy and the promise of new devices for telangiectasia. Dominik Heim (Switzerland)


Welcome Reception.  Exhibition Areas




Abstract Session 3: (10 minute presentation, 10 minute discussion)

Miscellaneous |  Chair: Mark Malouf (Australia)

08.30              3.1

The evolution of venous symptoms after interventional treatment for varicose veins.

Lobastov Kirill; Bargandzhiya Astanda; Laberko Leonid; Dvornikov Anton.

Pirogov Russian National Research Medical University, Moscow, Russia

08.50              3.2

Integral treatment of the pelvic congestion syndrome (intra and extra pelvic). Ibero-american pelvic study group.

Gural Romero Oscar1; Dándolo Marcelo1; Leal Monedero Javier2; Catalina Luis1; Zubicoa Ezpeleta Santiago3; Radiology; Mendiz, Oscar1; De Tommaso, Gonzalo1; Sanchez Guerrero, Angel4.

1Phlebolymphology Service, Favaloro Fundation, Buenos Aires, Argentina; 2Investigtion, Alcala of Henares University, Madrid, Spain; 3Radiology, Ruber International Hospital, Madrid, Spain; 4Radiology, Hospital October 12, Madrid, Spain

09.10              3.3

Evaluation of microvalve alteration and assessment of MPFF treatment in an experimental model of venous hypertension.

Bouskela, Eliete1; Garcia de Almeida Cyrino, Fatima Zely1; Blanc-Guillemaud, Vanessa2;

Cardiovascular and Metabolic Diseases Center for Therapeutic Innovation; Lucien, Arnaud2; Cardiovascular and Metabolic Diseases Center for Therapeutic Inn1 Laboratory for Clinical and Experimental Research on Vascular Biology, Biomedical Center, State University of Rio de Janeiro, Rio de Janeiro, Brazil; 2Institut de Recherches Internationales Servier (I.R.I.S.), Suresnes Cedex, France

09.30              3.4

The impact of lower body compression garment on left ventricular rotational mechanics in patients with secondary leg lymphedema and lipedema.

Szolnoky, Gyozo1; Kormányos, Árpád2; Domsik, Péter2; Kalapos, Anita2; Kemény, Lajos1; Forster, Tamás2; Nemes, Attila2;

1Department of Dermatology and Allergology; 22nd Department of Medicine and Cardiology Centre, University of Szeged, Szeged, Hungary

09.50              3.5

Factors, which are secreted by the venous endothelium upon exposure to oscillatory shear stress, affect adjacent cell layers of the vein wall.

Smetanina Mariia1; Shirshova Arina2; Zolotukhin Igor3; Shevela Andrey1 Filipenko Maxim1;

1Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine (ICBFM); Novosibirsk State University (NSU), Novosibirsk, Russia; 2Institute of Chemical Biology and Fundamental Medicine (ICBFM), Novosibirsk, Russia; 3Faculty of Surgery, Medical Department, Pirogov Russian National Research Medical University (RNRMU); Institute of Chemical Biology and Fundamental Medicine (ICBFM), Moscow, Russia

Submitted for the EVF Prize

10.10              3.6

V-move 2 v-care project: veines-QOL questionnaire was a valuable tool in assessing quality of life for patients presenting with venous ulcer in India over a 2 year period.

Jindal Ravul1; Gupta P2; Dekiwadia Devendra3;

1Fortis Hospital, Mohali, India; 2Private, Mumbai, India; 3Dekiwadia Hospital, Rajkot, India


Refreshments and visit to Exhibition  |  Visit e- Poster Presentations


Industry Session 2:


EVF Invited Lecture  |  Chair: I Bihari (Hungary)


The Best Vein Care is the Only Vein Care to be Considered.  P Gloviczki (USA)


Lunch and visit to Exhibition  |  ePoster Presentations


EVF Annual General Meeting (Members Only)


Joint EVF/AVF Session (10 minute presentations, 5 minute discussion)

Current Controversies   |  Chair: TBA, Z Pecsvarady (Hungary)


Iliac vein stenting for patients with the PTS. S Black (UK)


Thrombolysis in the prevention of PTS. N Baekgaard (Denmark)


Speaker from AVF Leadership


Speaker from AVF Leadership


Refreshments and visit to Exhibition  |  Visit to e-Poster Presentations


Industry Session 3:


Prize winning papers from the American Venous Forum, American Vein and Lymphatic Society and Japanese Society of Phlebology

(10 minute presentation, 5 minute discussion)  |  Chair:


Presentation from American Venous Forum (AVF)


Presentation from American College of Phlebology (ACP)


Presentation from Japanese Society of Phlebology (JSP)


Congress Dinner




Abstract Session 4: (10 minute presentation, 10 minute discussion)

Sclerotherapy, laser, Glue  |  Chair: TBA, I Rozsos (Hungary)

08.30            4.1

The effect of the length and caliber of the needle on the stability of sclerosant foam.

Simka Marian; Hobot Jacek; Skuła Marcin

Department of Anatomy, University of Opole, Opole, Poland

08.50            4.2

Endovenous laser ablation (EVLT) with simultaneous sclerotherapy as a comprehensive approach to superficial venous pathology treatment.

Jaworucka- Kaczorowska Aleksandra.

Center of Phlebology and Aesthetic Medicine, Gorzów Wlkp., Poland

09.10            4.3

Incidence of nerve injury after endovenous laser ablation for incompetent great saphenous veins.

Utoh Junichi1; Utoh Mei1; Tsukamoto, Yoshiharu2

1Kumamoto Vascular Clinic, Kumamoto, Japan; 2Kikuchi Central Hospital, Kikuchi, Japan

09.30            4.4

Reducing hyperpigmentation after sclerotherapy (RHYAS) study: results of a multicenter, controlled, randomized clinical trial.

Gonzalez Ochoa, Alejandro1; Carrillo Joaquin2; Manriquez Diana2; Nuricumbo Alejandro3.

1Hospital General Zona #12 Instituo Mexicano Seguro Social, San Luis Rio Colorado, Mexico; 2Vascular Surgery, Instituto Seguridad Social al Servicio de Trabajadores del Estado, Mexicali, Mexico; 3Vascular Surgery, Instituto Seguridad Social al Servicio de Trabajadores del Estado de Baja California, Mexicali, Mexico

09.50            4.5

Comparison of laser and glue in perforator vein treatment.

Bihari, Peter1; Ayoub, George1; Bihari, Imre2

1A+B Clinic, Budapest, Hungary; 2A and B Clinic, Budapest, Hungary

10.10            4.6

Relevance of systematic vascular ultrasound evaluation post foam sclerotherapy procedures.

Heil Arostegui Pacheco Carolina; Arêas Marques Marcos; de Matos Milhomens Ana Leticia; Lascasas Porto Carmen Lucia; Santos Miller Cintia; de Oliveira Chimeli Luisa; Tiemi Kano Silva Aline; Souza de Oliveira Lais; de Miranda Vieira Juliana.

State University of Rio de Janeiro, Rio de Janeiro, Brazil


Refreshments and visit to Exhibition


Didactic Session 3: (10 minute presentation, 5 minute discussion)

Varicose vein recurrence, compression, DOAC  |  Chair: TBA, G Menyhei (Hungary)


A score system to predict varicose vein recurrence. I Bihari (Hungary)


Small saphenous vein treatment issues. F Zernovicky (Hungary)


UEMS European Board of Phlebology. JJ Guex (France)


Phlebology training: instructions for trainers and trainees. O Maleti (Italy)


Abstract Session 5: 4 papers (10 minute presentation, 5 minute discussion)

Laser, Pathophysiology of CVD; Villalta Scale  |  Chairmen:

12.00            5.1

The evaluation of sensory nerve injury after endovenous laser ablation of the great saphenous vein depending on the type of anaesthesia.

Vlachovsky Robert; Staffa Robert.

2nd Department of Surgery, St.Anne´s University Hospital, Masaryk University Brno, Brno, Czech Republic

12.15            5.2

Will padding the leg to a perfect circular shape give an even pressure during compression treatment?

Lundh Torbjörn1; Baaz, Marcus2; Nilsson Andreas3

1Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden; 2University of Gothenburg, Gothenburg, Sweden; 3PressCise, Herrljunga, Sweden

12.30           5.3

Mathematical modeling of the venous walls’ and valves’ deformations.

Goranova Elena1; Nikolov Nikola2;

1Medical institute, Sofia, Bulgaria; 2 Fluids Mechanic Department, Bulgarian Academy of Sciences, Sofia, Bulgaria

12.45            5.4

Post-thrombotic syndrome in patients with double popliteal vein.

Minkova Boryana1; Dimitrov Svetoslav2; Daskalov Alexandar1; Vassil, Chervenkoff1;

1Vascular Surgery, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria; 2Vascular and Endovascular Surgery, Saint Ekaterina University Hospital, Sofia, Bulgaria


Joint EVF/BVF Session (10 minute presentation, 5 minute discussion)  |  Chair: E Goranova, A Giannoukas


A new validated classification of deep venous obstruction.  TBC


Haemodynamic assessment of outflow obstruction.  TBC


Speaker from BVF


Speaker from BVF


End of Meeting  |  Presentation of 2022 Meeting


Comments are closed.